Kroger Shares Rise, Pharmacies Add Eli Lilly Zepbound KwikPen - Kroger (NYSE:KR), Eli Lilly (NYSE:LLY)

Kroger Shares Rise, Pharmacies Add Eli Lilly Zepbound KwikPen - Kroger (NYSE:KR), Eli Lilly (NYSE:LLY)

The Kroger Co. (NYSE:KR) shares are up on Friday as the company expands access to high-demand weight management medication. The company confirmed the launch of Zepbound KwikPen at participating Kroger pharmacies. The Zepbound KwikPen is a multi-dose delivery option for Eli Lilly and Company’s (NYSE:LLY) GLP-1 therapy, now available for self-pay patients. Kroger’s stock performance is moving in tandem with the overall market trends, with the cons…

Kroger pharmacies add Zepbound KwikPen

CINCINNATI — The Kroger Co. announced that the Zepbound KwikPen, a newly introduced multi-dose delivery method for the weight-management therapy developed by Eli Lilly and Company, is now available at participating Kroger pharmacies.The move adds another retail pharmacy channel for the rapidly expanding GLP-1 obesity treatment, which has gained quick adoption as employers, digital health platforms, and pharmacy providers introduce new access and…

Kroger Brings Zepbound® KwikPen to Retail Pharmacy, Expanding Access and Savings for Self-Pay Patients

CINCINNATI, March 13, 2026 /PRNewswire/ — Today The Kroger Co. (NYSE: KR) and The Kroger Family of Pharmacies announced that as part of its continued commitment to expanding access to high-demand GLP-1 therapies, Zepbound® KwikPen – the newly launched, multi-dose delivery option of Eli Lilly’s weight-management medication – is now available at participating Kroger pharmacies, bringing patients a more convenient option for obtaining their medicat…